docetaxel anhydrous has been researched along with Intestinal Perforation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ángeles-Bueno, WG; Díaz-Sifuentes, JM; Mendoza-Medina, DF; Mendoza-Sánchez, F; Montes-López, GA; Pérez-Landeros, JE | 1 |
| Kanazawa, Y; Uchida, E; Yamada, T; Yokoi, K | 1 |
| DiMaio, MA; Erdrich, J; Kastenberg, ZJ; Longacre, TA; Rhoads, KF | 1 |
| Ardisson, P; Asmane, I; Bajard, A; Bergerat, JP; Coeffic, D; Dufresne, A; Guastalla, JP; Kurtz, JE; Labidi Galy, I; Meeus, P; Moullet, I; Ray-Coquard, I; Tredan, O; Vincent, L | 1 |
| Colucci, G; Dejaco, H; Grones, A; Marsoner, H; Thaler, W | 1 |
| Gibb, RK; Hagemann, A; Mutch, DG; Norris, L; Powell, MA; Rader, JS; Viviano, D; Wright, JD | 1 |
2 review(s) available for docetaxel anhydrous and Intestinal Perforation
| Article | Year |
|---|---|
Use of synthetic stomata in abdominal carcinomatosis. Case report and literature review.
Topics: Adenocarcinoma, Papillary; Adult; Antineoplastic Combined Chemotherapy Protocols; Argon Plasma Coagulation; Bevacizumab; Carboplatin; Combined Modality Therapy; Cytoreduction Surgical Procedures; Docetaxel; Doxorubicin; Drainage; Fatal Outcome; Female; Humans; Hyperthermia, Induced; Intestinal Neoplasms; Intestinal Perforation; Mitomycin; Ovarian Neoplasms; Polyethylene Glycols; Surgical Stomas | 2019 |
Colonic rupture in a patient on combination chemotherapy for metastasized carcinoma of the esophagogastric junction. Case report and review of the literature.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cecal Diseases; Cisplatin; Colonic Diseases; Docetaxel; Esophagogastric Junction; Female; Fluorouracil; Humans; Intestinal Perforation; Middle Aged; Rupture; Stomach Neoplasms; Taxoids; Treatment Outcome | 2005 |
4 other study(ies) available for docetaxel anhydrous and Intestinal Perforation
| Article | Year |
|---|---|
A case of gastric cancer with perforation caused by chemotherapy with docetaxel and S-1.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Fatal Outcome; Humans; Intestinal Perforation; Male; Oxonic Acid; Radiography, Abdominal; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed | 2013 |
Collateral damage: taxane-induced colonic perforation.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Colectomy; Colonic Diseases; Colostomy; Docetaxel; Enterocolitis; Female; Humans; Intestinal Perforation; Neoadjuvant Therapy; Predictive Value of Tests; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Ovarian Epithelial; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Female; Humans; Intestinal Fistula; Intestinal Perforation; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Rectovaginal Fistula; Retrospective Studies; Taxoids; Treatment Outcome; Urinary Bladder Fistula; Vascular Endothelial Growth Factor A; Vinblastine; Vinorelbine | 2011 |
Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: A retrospective analysis.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cohort Studies; Cyclophosphamide; Deoxycytidine; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Female; Fluorouracil; Gemcitabine; Humans; Intestinal Perforation; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum Compounds; Retrospective Studies; Taxoids; Tomography Scanners, X-Ray Computed; Treatment Outcome | 2006 |